politics
FDA panel recommends mRNA flu vaccine for older adults
Why this matters: political developments that affect policy direction and public trust.
A first-of-its-kind flu shot is a step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for approval. The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the
Read full story on The Hill → More top storiesAlso covered by
The Guardian
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
STAT News
STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy
NPR News
Key FDA committee unanimously recommends its first vaccine since 2023
Investing.com
Trump administration asks appeals court to let Kennedy pick vaccine panel members
Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop